What is RootPath?
RootPath is a synthetic biology company focused on significantly enhancing the throughput of gene function interrogation. Leveraging its molecular programming-based DNA fragment assembly technology, the company provides researchers and drug developers with unparalleled access to accurate, long synthetic genes and their functional readouts. RootPath's mission is to enable biology at scale, addressing critical needs within the research and drug development communities.
How much funding has RootPath raised?
RootPath has raised a total of $11M across 1 funding round:
Other Financing Round
$11M
Other Financing Round (2020): $11M, investors not publicly disclosed
What's next for RootPath?
The recent major strategic investment indicates RootPath is likely in a scaling or expansion phase, aiming to further commercialize its innovative gene synthesis technology. This capital infusion is expected to accelerate product development, expand market reach, and potentially forge new partnerships within the biotechnology and pharmaceutical industries. The company's focus on enabling biology at scale positions it to be a key player in advancing genetic research and therapeutic discovery.
See full RootPath company page
